India to get up to 500 million doses of Covid-19 vaccine: Harsh Vardhan

India plans to acquire 400 to 500 million doses of the Covid-19 vaccine to protect the population from 20 to 25 crore, and states have already been asked to present main points on the population teams of precedence expected to get the first circular of beatings through the end of the month, the Minister of Health said Sunday Harsh Vardhan.

“Frontline health workers would be given the highest priority,” Vardhan said in an online Q&A session. He also said the source of the vaccine would be centralized and that the shipment would be tracked in real time, the minister said.

The list of frontline fitness personnel will include doctors, nurses, paramedics, fitness personnel, ASHA officials, follow-up officers and many other occupational categories related to patient research, detection and treatment.

This training is expected to be completed until the end of October, and states are strongly oriented to also present the main points of bloodless chain services and other similar infrastructure that will be required up to the block level. Human resources, education and supervision, etc. , on a large scale, Vardhan said.

A high-level committee led by VK Paul, Member (Health), NITI Aayog, is being implemented to perceive the timing of vaccine availability in the country, ensuring the commitment of vaccine brands to achieve the maximum number of doses for stock and origin in India. management of the chain and also in the prioritization of high-risk groups. This is an ongoing table that will be completed when vaccines are in a position for immediate deployment of the immunization program.

Answering one question, he stated that it is not imaginable to comment on the superiority of one vaccine over another, although he promises that “even if we have several vaccines available, they will all be safe and cause the required immune reaction to the new coronavirus. “

He said that all vaccines that proved safe, immunogenic and effective in outdoor clinical trials in India will also have to go through transition studies to show their protection and immunogenicity to the Indian population, such studies can be conducted with a much smaller amount. samples and can finish quickly.

By sharing his perspectives on single-dose or double-dose vaccines, Vardhan stated that for immediate control of the pandemic, it is desirable to have a single-dose vaccine, but it is difficult to achieve the desired degrees of immune coverage by using a single person dose. He added that two-dose vaccines are tailored to achieve the desired immunogenicity because the first dose provides some immune coverage and the moment dose increases it even further.

Meanwhile, the total number of cases shown of Covid-19 in the country affected approximately 65. 5 lakh and the number of other people recovered exceeded the mark of 55 lakh. In the last 24 hours, just over 75,000 others tested positive, while more than 82,000 have recovered. The death toll of Covid-19 in the country is 101782.

Do you already have an account? Connect

Start your 14-day loose trial. Register

Get full virtual playback of The Hindu BusinessLine, The Hindu, Frontline, Sportstar, Crossword, Epaper from The Hindu and The Hindu BusinessLine at A SINGLE REDUCED PRICE.

Gain a diverse set of knowledge from our experts in portfolio, banking, economics, environment and more.

Access Hindu Businessline content on desktops, tablets, and mobile devices.

Discover an ad-free cleaner with faster charging times

Customize your personal tastes and get personalized advice on your interest.

Greater

Leave a Comment

Your email address will not be published. Required fields are marked *